Precio de cierre
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
10,26 CNY | -0,48 % | -0,68 % | -32,32 % |
Resumen de negocios
Número de empleados: 2 468
Ventas por actividad
CNY en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Respiratory Medicine
59,9
%
| 933 | 61,6 % | 1 140 | 59,9 % | +22,26 % |
Digestive System Medicine
21,0
%
| 362 | 23,9 % | 400 | 21,0 % | +10,50 % |
Other Drugs
11,4
%
| 92 | 6,1 % | 218 | 11,4 % | +135,87 % |
Systemic Anti-infective Drugs
7,7
%
| 128 | 8,4 % | 147 | 7,7 % | +14,75 % |
Ventas por región
CNY en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
China
100,0
%
| 1 515 | 100,0 % | 1 905 | 100,0 % | +25,75 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Jing Ping Liu
CEO | Chief Executive Officer | 54 | 01/12/07 |
Peng Xu
CHM | Chairman | 61 | 01/03/10 |
Hui Yu
DFI | Director of Finance/CFO | 40 | 08/07/22 |
Jun Ling Li
BRD | Director/Board Member | 56 | 01/09/18 |
Bao Kun Wan
BRD | Director/Board Member | 62 | 01/04/12 |
Ping Liu
BRD | Director/Board Member | 51 | 01/03/12 |
Hai Yan Wang
IRC | Investor Relations Contact | 37 | 01/03/20 |
Qing Tao Wang
SEC | Corporate Secretary | 42 | 01/03/15 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Gui Hua Wang
BRD | Director/Board Member | 63 | 16/11/18 |
Jing Ping Liu
CEO | Chief Executive Officer | 54 | 01/12/07 |
Ping Liu
BRD | Director/Board Member | 51 | 01/03/12 |
Bao Kun Wan
BRD | Director/Board Member | 62 | 01/04/12 |
Hui Yu
DFI | Director of Finance/CFO | 40 | 08/07/22 |
Jun Ling Li
BRD | Director/Board Member | 56 | 01/09/18 |
Qi Bo Tang
BRD | Director/Board Member | 36 | 04/11/22 |
Shi Xian Wang
BRD | Director/Board Member | 48 | 04/11/22 |
Qiu Yun Liu
BRD | Director/Board Member | 45 | 04/11/22 |
Peng Xu
CHM | Chairman | 61 | 01/03/10 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 400 108 752 | 83 526 717 ( 20,88 %) | 0 | 20,88 % |
Información de la empresa
Hainan Huluwa Pharmaceutical Group Co., Ltd.
8, Yaogu 4th Road Phase II, Yaogu Industrial Park
570311, Haikou
+
http://www.huluwayaoye.comVentas por actividad
Varia. 1 de ene. | Capi. | |
---|---|---|
-32,32 % | 569 M | |
+51,82 % | 791 mil M | |
+40,45 % | 630 mil M | |
+16,95 % | 328 mil M | |
+9,49 % | 298 mil M | |
+17,25 % | 246 mil M | |
+0,41 % | 225 mil M | |
+10,22 % | 218 mil M | |
+5,30 % | 160 mil M | |
-6,29 % | 156 mil M |
- Bolsa de valores
- Acciones
- Acción 605199
- Empresa Hainan Huluwa Pharmaceutical Group Co., Ltd.